Presentation at SMISS Plenary Session of SpineGuard's DSG® Robotic Technology Confirming Excellent Outcomes in Bone Breach Detection
15 November 2021 - 8:30AM
Business Wire
Regulatory News:
SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an
innovative company that deploys its DSG (Dynamic Surgical Guidance)
sensing technology to secure and streamline the placement of bone
implants, announced today that Dr. Larry T. Khoo presented in
plenary session of the congress of the Society for Minimally
Invasive Spine Surgery (SMISS) the experimental results of the
robotic application of its DSG technology.
DSG is based on the local measurement of electrical conductivity
of tissues in real time without X-ray imaging, with a sensor
located at the tip of the drilling instrument. Its efficacy was
proven by more than 85,000 surgeries across the globe and 17
scientific publications. SpineGuard has entered in 2017 a
collaboration with the ISIR (Institut des Systèmes Intelligents et
de Robotique) lab of Sorbonne University, CNRS and INSERM, for the
application of DSG to surgical robots and the enhancement of their
safety, accuracy and autonomy. The experiment results presented at
SMISS consisted in the boundary detection between bone and soft
tissues during vertebral drilling performed by a robot, and in
automatically stopping the drilling as the tip reached this
limit.
SMISS (Society for Minimally Invasive Spine Surgery) is one of
the major spine surgery congresses in the world. Founded in the USA
in 2007, and with international inclusion, it was the first to
focus on innovation, scientific research and teaching of minimally
invasive approaches to spine surgery. It is the main reference in
this arena. The annual SMISS meeting was held in Las Vegas last
weekend; Dr. Khoo presented in plenary session on Saturday Oct.
30th the experimental results of DSG applied to robotics.
These results are the fruit of the collaboration between the
researchers of SpineGuard and Sorbonne University, J.DaSilva,
E.Saghbiny, G.Morel, T.Chandanson, S.Bette with the Scientific
Advisory Board of SpineGuard composed of R.Assaker (France), R.Betz
(USA), C.Bolger (Ireland), M.Bourlion (France), H.Defino (Brazil),
A.Kaelin (Switzerland), L.Khoo (USA), J.Williams (USA), HK.Wong
(Singapore).
This presentation is a key milestone because it is a validation
by the scientific community of the relevance of the results, it
comes naturally as a support to SpineGuard's strategic discussions
with the industry, aiming at the integration of DSG in robotic
assistance surgical platforms.
Dr. Larry Khoo, minimally invasive Spine Surgery specialist
at the Spine Clinic of Los Angeles (USA) and member of the
Scientific Advisory Board (SAB) of SpineGuard declares: "Robots
all give the surgeon a trajectory, but the problem is that the
trajectory is not always as accurate as we would like to believe
because certain basic rules of physics and engineering cannot be
overcome when using long instruments, resulting in a possible +- 2
or 3mm range of error at the tip. In contrast, DSG is designed for
providing real live feedback from the tip with a very high ability
to predict or prevent a breach. This opens up a great new area of
research with control algorithms beyond robotic assistance towards
automated placement of screws and rods."
The algorithms used are property of SpineGuard, Sorbonne
University, INSERM and CNRS. The verification work received funding
from the European Union’s Horizon 2020 research and innovation
program, in the context of the FAROS project (Functional Accurate
RObotic Surgery) under grant agreement No 101016985.
SpineGuard is focused on the following priorities while striving
to remain close to breakeven:
- Boost commercial activities with the launch of the DSG-Connect
visual interface.
- Implement the DSG digital technology in ortho-robotics through
the deployment of AI algorithms, scientific evidence, and
additional patents.
- Intensify the collaboration with ConfiDent ABC for the dental
application and co-develop a new generation of products embedding
the DSG technology.
- Affirm the company’s technological shift and sign strategic
partnerships in particular for the use of DSG technology in the
robotic field.
About SpineGuard®
Founded in 2009 in France and the USA by Pierre Jérôme and
Stéphane Bette, SpineGuard is an innovative company deploying its
proprietary radiation-free real time sensing technology DSG®
(Dynamic Surgical Guidance) to secure and streamline the placement
of implants in the skeleton. SpineGuard designs, develops and
markets medical devices that have been used in over 85,000 surgical
procedures worldwide. Seventeen studies published in peer-reviewed
scientific journals have demonstrated the multiple benefits DSG®
offers to patients, surgeons, surgical staff and hospitals.
Building on these solid fundamentals and several strategic
partnerships, SpineGuard has expanded its technology platform in a
disruptive innovation: the « smart » pedicle screw launched late
2017 and is broadening the scope of applications in dental
implantology and surgical robotics. DSG® was co-invented by Maurice
Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem,
Biomedical Engineer. SpineGuard has engaged in multiple ESG
initiatives.
For further information, visit www.spineguard.com
Disclaimer
The SpineGuard securities may not be offered or sold in the
United States as they have not been and will not be registered
under the Securities Act or any United States state securities
laws, and SpineGuard does not intend to make a public offer of its
securities in the United States. This is an announcement and not a
prospectus, and the information contained herein does and shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of the securities referred to herein in
the United States in which such offer, solicitation or sale would
be unlawful prior to registration or exemption from
registration.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211114005045/en/
SpineGuard Pierre Jérôme CEO & Chairman Tel: +33 1 45
18 45 19 p.jerome@spineguard.com
SpineGuard Manuel Lanfossi CFO Tel: +33 1 45 18 45 19
m.lanfossi@spineguard.com
NewCap Investor Relations & Financial Communication
Mathilde Bohin / Pierre Laurent Tel.: +33 1 44 71 94 94
spineguard@newcap.eu
Spineguard (EU:ALSGD)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Spineguard (EU:ALSGD)
Historical Stock Chart
Von Apr 2023 bis Apr 2024